Yes—my understanding was, as you note, that the right clean rooms are still orders of magnitude too expensive on a capital & ongoing basis to produce meat at consumer prices. The difference from the pharma industry is that they charge orders of magnitude more per volume of product, which can support this cost. I also understand that splitting reactors might not be a favourable clean trade-off either, since at the same volume, 10x1kL reactors take up more space (and therefore more clean room costs) & are more expensive to operate.
Reading your reply, is it correct that the major cultivated meat companies won’t be able to hit consumer pricing or scale anytime soon because of those major technological breakthroughs they need to achieve first?
Yes—my understanding was, as you note, that the right clean rooms are still orders of magnitude too expensive on a capital & ongoing basis to produce meat at consumer prices. The difference from the pharma industry is that they charge orders of magnitude more per volume of product, which can support this cost. I also understand that splitting reactors might not be a favourable clean trade-off either, since at the same volume, 10x1kL reactors take up more space (and therefore more clean room costs) & are more expensive to operate.
Reading your reply, is it correct that the major cultivated meat companies won’t be able to hit consumer pricing or scale anytime soon because of those major technological breakthroughs they need to achieve first?